Topotarget skal præsentere på 15th Annual Rodman & Renshaw Global Investment Conference
30 août 2013 08h46 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 08-13 / København, 30. august 2013
Topotarget skal præsentere på 15th Annual Rodman & Renshaw Global Investment Conference, som afholdes i...
Første patient doseret i første del af bekræftende BelCHOP-studie i PTC
28 août 2013 05h01 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 22-13 / København, 28. august 2013
Topotarget meddeler hermed, at den første patient har fået dosis i studiet til fastsættelse af dosis af belinostat...
First patient dosed in part one confirmatory BelCHOP study in PTCL
28 août 2013 05h01 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 22-13 / Copenhagen, August 28, 2013
Topotarget announces that the first patient has been dosed in the dose-finding study of belinostat in...
Topotarget offentliggør delårsrapport 2. kvartal 2013
14 août 2013 02h27 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 21-13 / København, 14. august 2013
Topotarget meddeler, at bestyrelsen i dag har behandlet og godkendt selskabets delårsrapport for perioden 1....
Topotarget announces interim report for Q2 2013
14 août 2013 02h27 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 21-13 / Copenhagen, August 14, 2013
Topotarget announces that the board of directors has reviewed and approved the company’s interim report for the...
Spectrum Pharmaceuticals announces postponement in filing of NDA for belinostat in PTCL to Q4 2013
08 août 2013 03h50 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 20-13 / Copenhagen, August 8, 2013
On August 7, 2013, Spectrum Pharmaceuticals announced that the filing of the New Drug Application (NDA) for...
Spectrum Pharmaceuticals offentliggør udskydelse af indlevering af registreringsansøgning for belinostat i PTCL til 4. kvartal 2013
08 août 2013 03h50 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 20-13 / København, 8. august 2013
Den 7. august 2013 offentliggjorde Spectrum Pharmaceuticals, at indleveringen af registreringsansøgningen (NDA) for...
Topotarget announces the time and date for the telephone conference related to the publishing of the interim report for Q2 2013
06 août 2013 08h38 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 07-13 / Copenhagen, August 6, 2013
Topotarget announces that a teleconference will be held on August 14, 2013 at 1:00 pm CET.
CEO Anders Vadsholt...
Topotarget offentliggør tid og dato for telefonkonference vedr. offentliggørelse af delårsrapport for 2. kvartal 2013
06 août 2013 08h38 HE
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 07-13 / København, 6. august 2013
Topotarget meddelte i dag, at der vil blive afholdt en telefonkonference den 14. august 2013 kl. 13.00 dansk...
Belinostat gets European orphan drug designation for the treatment of malignant thymomas
18 juil. 2013 07h03 HE
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 19-13 / Copenhagen, July 18, 2013
On July 17, 2013, the European Commission granted Topotarget an orphan drug designation for belinostat...